emergency use featured image
News Pharmaceutical & Biotech Stories

Chile Approves EU of China’s Vaccine for Children Aged 6-17

Monday, September, 6, Chile’s Institute of Public Health (ISP) approved the emergency use of the Sinovac CoronaVac vaccine for children and adolescents aged from 6 to 17.

According to a report, ISP Director Heriberto Garcia made the announcement at a press conference, “In order to continue protecting the population, we have approved the CoronaVac vaccine for children aged six and up. The data shows the number of infected children is rising due to the fact that they are not vaccinated.”

The ISP experts highlighted the safety of the Sinovac CoronaVac vaccines and their tested immunogenic response.

The ISP approved the emergency use of Sinovac CoronaVac vaccines for those aged 18 or over on Jan. 20 this year.

ASEAN HR TECH VENTURE SUMMIT 2018
REGISTER NOW 33% DISCOUNT
SUMMIT PASS